Literature DB >> 16813177

[Clinical observation and study of mechanisms of needle-picking therapy for primary infertility of abnormal sperm].

Chen Dong1, Shu-ren Chen, Jie Jiang, Yuan-hui Xiao, Ming-xue Cai, Yue-juan Zhang, Hao Xu, Lie-hua Deng, Shu Li.   

Abstract

OBJECTIVE: To search for the best method for increasing clinical therapeutic effect on primary abnormality of sperm.
METHODS: One hundred and sixty-eight cases of infertility were randomly divided into a treatment group of 85 cases and a control group of 83 cases. The treatment group were treated with needle-picking at bilateral Shengzhi points, Dicong Shenjing points and L2 Shenjing points as main. The control group were treated with oral administration of Wuzi Yanzong Pills [symbol: see text]. Their therapeutic effects were observed in 3 hospitals.
RESULTS: The total effective rate of 83.5% and the pregnancy rate of the patient's wife of 78.8% in the treatment group, and corresponding figures were 54.2% and 43.4% in the control group, with a very significant difference between the two groups (P < 0.01); and reproductive hormones improved significantly after treatment in the two groups (P < 0.01); after treatment, superoxide dismulase (SOD) activity and Zn content in semen were elevated and cadmium level decreased significantly in the treatment group (P < 0.05).
CONCLUSION: Needle picking therapy can significantly improve and regulate endocrine function, increase quality of semen and elevate pregnancy rate of the patient's wife for the patient of primary abnormal sperm.

Entities:  

Mesh:

Year:  2006        PMID: 16813177

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

Review 1.  Acupuncture for infertility: is it an effective therapy?

Authors:  Dong-mei Huang; Guang-ying Huang; Fu-er Lu; Dieterle Stefan; Neuer Andreas; Greb Robert
Journal:  Chin J Integr Med       Date:  2011-05-25       Impact factor: 1.978

2.  Unexplained infertility treated with acupuncture and herbal medicine in Korea.

Authors:  Jongbae J Park; Myungja Kang; Sangseop Shin; Eunmi Choi; Sukyung Kwon; Hyosun Wee; Bonghyun Nam; Ted J Kaptchuk
Journal:  J Altern Complement Med       Date:  2010-02       Impact factor: 2.579

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.